Impact of Region-of-Interest Size on Immune Profiling Using Multiplex Immunofluorescence Tyramide Signal Amplification for Paraffin-Embedded Tumor Tissues

Introduction: Representative regions of interest (ROIs) analysis from the whole slide images (WSI) are currently being used to study immune markers by multiplex immunofluorescence (mIF) and single immunohistochemistry (IHC). However, the amount of area needed to be analyzed to be representative of the entire tumor in a WSI has not been defined. Methods: We labeled tumor-associated immune cells by mIF and single IHC in separate cohorts of non-small cell lung cancer (NSCLC) samples and we analyzed them as whole tumor area as well as using different number of ROIs to know how much area will be need to represent the entire tumor area. Results: For mIF using the InForm software and ROI of 0.33 mm2 each, we observed that the cell density data from five randomly selected ROIs is enough to achieve, in 90% of our samples, more than 0.9 of Spearman correlation coefficient and for single IHC using ScanScope tool box from Aperio and ROIs of 1 mm2 each, we found that the correlation value of more than 0.9 was achieved using 5 ROIs in a similar cohort. Additionally, we also observed that each cell phenotype in mIF influence differently the correlation between the areas analyzed by the ROIs and the WSI. Tumor tissue with high intratumor epithelial and immune cells phenotype, quality, and spatial distribution heterogeneity need more area analyzed to represent better the whole tumor area. Conclusion: We found that at minimum 1.65 mm2 area is enough to represent the entire tumor areas in most of our NSCLC samples using mIF.

[1]  I. Wistuba,et al.  Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue , 2021, Scientific Reports.

[2]  I. Wistuba,et al.  Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues , 2021, Scientific Reports.

[3]  N. Ajami,et al.  Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial , 2021, Nature Medicine.

[4]  I. Wistuba,et al.  Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial. , 2020, The Lancet. Oncology.

[5]  J. Taube,et al.  The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation , 2020, Journal for immunotherapy of cancer.

[6]  I. Wistuba,et al.  A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non–Small Cell Lung Cancer , 2020, Clinical Cancer Research.

[7]  A. Fabro,et al.  Variants in Epithelial-Mesenchymal Transition and Immune Checkpoint Genes Are Associated With Immune Cell Profiles and Predict Survival in Non-Small Cell Lung Cancer. , 2020, Archives of pathology & laboratory medicine.

[8]  Mei Jiang,et al.  Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies , 2020, Cancers.

[9]  Douglas Bowman,et al.  Introduction to Digital Image Analysis in Whole-slide Imaging: A White Paper from the Digital Pathology Association , 2019, Journal of pathology informatics.

[10]  Paul Hofman,et al.  Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time? , 2019, Cancers.

[11]  Edwin Roger Parra,et al.  State-of-the-Art of Profiling Immune Contexture in the Era of Multiplexed Staining and Digital Analysis to Study Paraffin Tumor Tissues , 2019, Cancers.

[12]  Zhengming Chen,et al.  Hot Spot and Whole‐Tumor Enumeration of CD8+ Tumor‐Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple‐Negative Breast Cancer , 2018, Clinical breast cancer.

[13]  A. Behren,et al.  Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma , 2018, Scientific Reports.

[14]  Mei Jiang,et al.  Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues , 2017, Scientific Reports.

[15]  Jaime Rodriguez-Canales,et al.  Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients , 2016, Clinical Cancer Research.

[16]  Michael T. McCann.  Tools for Automated Histology Image Analysis , 2015 .

[17]  V. Rojo-León,et al.  Relationship of Dendritic Cell Density, HMGB1 Expression, and Tumor-infiltrating Lymphocytes in Non–Small Cell Lung Carcinomas , 2014, Applied immunohistochemistry & molecular morphology : AIMM.

[18]  Todd H. Stokes,et al.  Pathology imaging informatics for quantitative analysis of whole-slide images , 2013, Journal of the American Medical Informatics Association : JAMIA.

[19]  E. Mroz,et al.  MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. , 2013, Oral oncology.

[20]  May D. Wang,et al.  Biological interpretation of morphological patterns in histopathological whole-slide images , 2012, BCB.

[21]  Padraig Cunningham,et al.  Ensemble based system for whole-slide prostate cancer probability mapping using color texture features , 2011, Comput. Medical Imaging Graph..

[22]  Eduardo Romero,et al.  A supervised visual model for finding regions of interest in basal cell carcinoma images , 2011, Diagnostic pathology.

[23]  G. Soma,et al.  The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. , 2003, Anticancer research.

[24]  E. Kay,et al.  Infiltrating immune cells, but not tumour cells, express FasL in non‐small cell lung cancer: No association with prognosis identified in 3‐year follow‐up , 2003, International journal of cancer.

[25]  I. Takanami,et al.  Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma , 2000, Cancer.

[26]  K. Kerr,et al.  Immune cell infiltrates and prognosis in primary carcinoma of the lung. , 2000, Lung cancer.